175 related articles for article (PubMed ID: 30231526)
1. Binding Performance of Human Intravenous Immunoglobulin and 20(
Liu YC; Li YY; Yao XJ; Qi HL; Wei XX; Liu JN
Molecules; 2018 Sep; 23(9):. PubMed ID: 30231526
[TBL] [Abstract][Full Text] [Related]
2. Study on the interactions of kaempferol and quercetin with intravenous immunoglobulin by fluorescence quenching, fourier transformation infrared spectroscopy and circular dichroism spectroscopy.
Liu YC; Yang ZY; Du J; Yao XJ; Lei RX; Zheng XD; Liu JN; Hu HS; Li H
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):443-51. PubMed ID: 18379088
[TBL] [Abstract][Full Text] [Related]
3. Hydroxycamptothecin deactivation rates and binding to model membranes and HSA determined by fluorescence spectra analysis.
Ziomkowska B; Cyrankiewicz M; Kruszewski S
Comb Chem High Throughput Screen; 2007 Jul; 10(6):459-65. PubMed ID: 17896941
[TBL] [Abstract][Full Text] [Related]
4. Interaction of curcumin with intravenous immunoglobulin: a fluorescence quenching and Fourier transformation infrared spectroscopy study.
Liu Y; Yang Z; Du J; Yao X; Lei R; Zheng X; Liu J; Hu H; Li H
Immunobiology; 2008; 213(8):651-61. PubMed ID: 18950593
[TBL] [Abstract][Full Text] [Related]
5. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability.
Burke TG; Mi Z
J Med Chem; 1994 Jan; 37(1):40-6. PubMed ID: 8289200
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy.
Chourpa I; Millot JM; Sockalingum GD; Riou JF; Manfait M
Biochim Biophys Acta; 1998 Mar; 1379(3):353-66. PubMed ID: 9545598
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Taxol with intravenous immunoglobulin: an inhibition of Taxol from crystallizing in aqueous solution.
Liu Y; Yang Z; Du J; Yao X; Zheng X; Lei R; Liu J; Hu H; Li H
Int Immunopharmacol; 2008 Mar; 8(3):390-400. PubMed ID: 18279793
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
[TBL] [Abstract][Full Text] [Related]
9. Reduced albumin binding promotes the stability and activity of topotecan in human blood.
Mi Z; Malak H; Burke TG
Biochemistry; 1995 Oct; 34(42):13722-8. PubMed ID: 7577964
[TBL] [Abstract][Full Text] [Related]
10. The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity.
Bom D; Curran DP; Kruszewski S; Zimmer SG; Thompson Strode J; Kohlhagen G; Du W; Chavan AJ; Fraley KA; Bingcang AL; Latus LJ; Pommier Y; Burke TG
J Med Chem; 2000 Oct; 43(21):3970-80. PubMed ID: 11052802
[TBL] [Abstract][Full Text] [Related]
11. Traces of pFc' in IVIG interact with human IgG Fc domains and counteract aggregation.
Rispens T; Himly M; Ooievaar-De Heer P; den Bleker TH; Aalberse RC
Eur J Pharm Sci; 2010 Apr; 40(1):62-8. PubMed ID: 20211252
[TBL] [Abstract][Full Text] [Related]
12. Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.
Ivanova B; Spiteller M
Biopolymers; 2012 Feb; 97(2):134-44. PubMed ID: 21898362
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?
Chourpa I; Beljebbar A; Sockalingum GD; Riou JF; Manfait M
Biochim Biophys Acta; 1997 Mar; 1334(2-3):349-60. PubMed ID: 9101731
[TBL] [Abstract][Full Text] [Related]
14. Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution.
Underberg WJ; Goossen RM; Smith BR; Beijnen JH
J Pharm Biomed Anal; 1990; 8(8-12):681-3. PubMed ID: 2100606
[TBL] [Abstract][Full Text] [Related]
15. Human multidrug resistance associated protein 4 confers resistance to camptothecins.
Tian Q; Zhang J; Tan TM; Chan E; Duan W; Chan SY; Boelsterli UA; Ho PC; Yang H; Bian JS; Huang M; Zhu YZ; Xiong W; Li X; Zhou S
Pharm Res; 2005 Nov; 22(11):1837-53. PubMed ID: 16132345
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human serum albumin with 10-hydroxycamptothecin: spectroscopic and molecular modeling studies.
Sun HH; Zhang J; Zhang YZ; Yang LY; Yuan LL; Liu Y
Mol Biol Rep; 2012 May; 39(5):5115-23. PubMed ID: 22160573
[TBL] [Abstract][Full Text] [Related]
17. Binding interactions of water-soluble camptothecin derivatives with bovine serum albumin.
Li Q; Zhu Q; Deng X; He W; Zhao T; Zhang B
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 86():124-30. PubMed ID: 22051412
[TBL] [Abstract][Full Text] [Related]
18. Lipid bilayer partitioning and stability of camptothecin drugs.
Burke TG; Mishra AK; Wani MC; Wall ME
Biochemistry; 1993 May; 32(20):5352-64. PubMed ID: 8499440
[TBL] [Abstract][Full Text] [Related]
19. Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble camptothecin analog irinotecan hydrochloride.
Ishtikhar M; Khan MV; Khan S; Chaturvedi SK; Badr G; Mahmoud MH; Khan RH
J Biomol Struct Dyn; 2016 Jul; 34(7):1545-60. PubMed ID: 26309154
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus.
Ciotti M; Basu N; Brangi M; Owens IS
Biochem Biophys Res Commun; 1999 Jun; 260(1):199-202. PubMed ID: 10381366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
